World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
8275
World Ranking
4245
National Ranking
130

Overview

Carmen de Mendoza is affiliated with the Instituto de Salud Carlos III in Spain and has contributed extensively to the field of medicine, particularly focusing on infectious diseases and epidemiology. Their body of work spans several subfields, including hepatology, immunology, and agronomy and crop science.

Their research topics prominently include hepatitis C virus research, T-cell and retrovirus studies, hepatitis B virus studies, and SARS-CoV-2 and COVID-19 research. Additional focus areas are COVID-19 clinical research studies, long-term effects of COVID-19, and animal disease management and epidemiology.

Recent papers published by Carmen de Mendoza include:

  • Main differences between the first and second waves of COVID-19 in Madrid, Spain (2021) published in International Journal of Infectious Diseases
  • Third wave of COVID-19 in Madrid, Spain (2021) published in International Journal of Infectious Diseases
  • Bacterial infections in patients hospitalized with COVID-19 (2021) published in Internal and Emergency Medicine
  • Advances in hepatitis B therapeutics (2020) published in Therapeutic Advances in Infectious Disease
  • Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain (2021) published in International Journal of Infectious Diseases

Their frequent coauthors consist of Vincent Soriano, Víctor Moreno-Torres, Octavio Corral, Pablo Barreiro, and Ana Treviño.

The scientist often publishes in venues such as Aids Reviews, International Journal of Infectious Diseases, Journal of Clinical Virology, AIDS, and Liver International. Among these, Aids Reviews and International Journal of Infectious Diseases have been particularly prominent outlets for their work.

Best Publications

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.

    Pablo Barreiro;Jorge del Romero;Manuel Leal;Victoria Hernando

  • Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

    Priscilla Swanson;Carmen de Mendoza;Yagnya Joshi;Alan Golden

  • Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes

    Carolina Garrido;Vanessa Roulet;Natalia Chueca;Eva Poveda

  • The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

    Pillay D;Bhaskaran K;Jurriaans S;Prins M

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural Tanzania

    Asgeir Johannessen;Carolina Garrido;Natalia Zahonero;Leiv Sandvik

  • Main differences between the first and second waves of COVID-19 in Madrid, Spain.

    Vicente Soriano;Pilar Ganado-Pinilla;Miguel Sánchez-Santos;Felix Gómez-Gallego

  • Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

    José Vicente Fernández-Montero;Eugenia Vispo;Pablo Barreiro;Rocío Sierra-Enguita

  • Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

    Bernard Masquelier;Krishnan Bhaskaran;Deenan Pillay;Robert Gifford

  • Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

    Vincent Soriano;Pilar Garcia-Gasco;Eugenia Vispo;Andrés Ruiz-Sancho

  • Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

    Carolina Garrido;Natalia Zahonero;Angélica Corral;Miguel Arredondo

  • Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

    Tomas Doyle;David T. Dunn;Francesca Ceccherini-Silberstein;Carmen De Mendoza

  • Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.

    Oscar Gallego;Carmen De Mendoza;Maria Jesus Perez-Elias;Josep Maria Guardiola

  • High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients

    Silvina Masciotra;Carolina Garrido;Ae S Youngpairoj;Amanda McNulty

  • Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance

    Carmen de Mendoza;Carmen Rodriguez;Federico García;José M Eiros

  • High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

    Eduardo Seclén;Carolina Garrido;María del Mar González;Juan González-Lahoz

  • Plasmid-determined resistance to fosfomycin in Serratia marcescens.

    C Mendoza;J M Garcia;J Llaneza;F J Mendez

  • Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain

    Carmen de Mendoza;Carmen Rodriguez;Javier Colomina;Concepción Tuset

Frequent Co-Authors

Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Pablo Barreiro
Pablo Barreiro Hospital Universitario La Paz
Pablo Labarga
Pablo Labarga Instituto de Salud Carlos III
Juan González-Lahoz
Juan González-Lahoz Instituto de Salud Carlos III
José Ramos
José Ramos University of Córdoba
Luz Martín-Carbonero
Luz Martín-Carbonero Hospital Universitario La Paz
Marina Núñez
Marina Núñez Wake Forest University
Dimitrios Paraskevis
Dimitrios Paraskevis National and Kapodistrian University of Athens
Francisco J. Blanco
Francisco J. Blanco University of A Coruña
Kholoud Porter
Kholoud Porter University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career paths and further educational opportunities, many of which can be pursued online. For individuals facing unique challenges, such as those re-entering the workforce, there are options like online colleges that accept felons, providing a fresh start alongside valuable knowledge in the sciences.

Healthcare is a prominent field where microbiology graduates can thrive. Becoming a functional nurse practitioner integrates microbiology principles with patient-centered care, emphasizing holistic treatment approaches.

Alternatively, those interested in the intersection of healthcare and technology might pursue certifications like the certified professional coder certification. This path leverages analytical skills essential for accurate medical coding and billing, a critical aspect of healthcare management.

Finally, advancing in healthcare administration through a master in health information management salary programs can lead to rewarding roles managing complex health data systems—key for modern medical facilities.

Best Scientists Citing Carmen de Mendoza

Trending Scientists